Lucid Diagnostics Inc (LUCD) PT Lowered to $3.80 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Ross Osborn lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $3.80 (from $4.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
